Study of vortex valve for medium temperature solid propellants

Fluid state vortex valve secondary injection control system shows considerable promise for future application to solid propellant rocket engine thrust vector control. The single axis injection system tested would be capable of providing secondary injection thrust vector control using 2000 deg F gas

Research study of the vortex valve for medium-temperature solid propellants

Fluid state control system with vortex valves for solid propellant gas generator flow throttlin

Yield and compatibility of ten tomato scion varieties grafted with ‘Maxifort’ rootstock

Many urban and peri-urban tomato growers are adopting the use of grafted plants to help reduce disease incidence and/or improve crop yields, particularly in high tunnel systems. However, little is known about how scion cultivar selection plays a role or if there is a similar impact across scion cultivars in regard to fruit yield. In our study, ten hybrid, determinate, red slicing tomato (Solanum lycopersicum) varieties were evaluated as scions for ‘Maxifort’ rootstock. Trials were conducted in 2016 and 2017 in a three-season high tunnel in Olathe, KS. All ten scion varieties were found to be compatible with ‘Maxifort’. However, ‘BHN 589’, ‘Red Deuce’, ‘Skyway’, and ‘Tasti Lee’ showed significant improvements in marketable yield when grafted to ‘Maxifort’ indicating that they were “highly compatible” with the rootstock. Grafted ‘Red Deuce’ and ‘BHN 589’ scions had the highest fruit yield of any of the treatments that we tested and ranged from to 21.4 to 23.0 lbs of marketable fruit per plant. Nongrafted ‘Primo Red’ was also a good option for high tunnel production and provided 19.2 lbs of marketable fruit per plant. The results of this study suggest that not all scion cultivars respond to grafting with ‘Maxifort’ rootstock in the same manner and we attempted to assess their compatibility based on crop productivity

International workshop on immune tolerance induction: consensus recommendations 1

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73382/1/j.1365-2516.2007.01497.x.pd

Benefits of actinide-only burnup credit for shutdown PWRs

Owners of PWRs that are shutdown prior to resolution of interim storage or permanent disposal issues have to make difficult decisions on what to do with their spent fuel. Maine Yankee is currently evaluating multiple options for spent fuel storage. Their spent fuel pool has 1,434 assemblies. In order to evaluate the value to a utility of actinide-only burnup credit, analysis of the number of canisters required with and without burnup credit was made. In order to perform the analysis, loading curves were developed for the Holtec Hi-Star 100/MPC-32. The MPC-32 is hoped to be representative of future burnup credit designs from many vendors. The loading curves were generated using the actinide-only burnup credit currently under NRC review. The canister was analyzed for full loading (32 assemblies) and with partial loadings of 30 and 28 assemblies. If no burnup credit is used the maximum capacity was assumed to be 24 assemblies. this reduced capacity is due to the space required for flux traps which are needed to sufficiently reduce the canister reactivity for the fresh fuel assumption. Without burnup credit the 1,343 assemblies would require 60 canisters. If all the fuel could be loaded into the 32 assembly canisters only 45 canisters would be required. Although the actinide-only burnup credit approach is very conservative, the total number of canisters required is only 47 which is only two short of the minimum possible number of canisters. The utility is expected to buy the canister and the storage overpack. A reasonable cost estimate for the canister plus overpack is $500,000. Actinide-only burnup credit would save 13 canisters and overpacks which is a savings of about$6.5 million. This savings is somewhat reduced since burnup credit requires a verification measurement of burnup. The measurement costs for these assemblies can be estimated as about $1 million. The net savings would be$5.5 million

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology

AbstractPurposeThe Nuclear Regulatory Commission deems it to be a medical event (ME) if the total dose delivered differs from the prescribed dose by 20% or more. A dose-based definition of ME is not appropriate for permanent prostate brachytherapy as it generates too many spurious MEs and thereby creates unnecessary apprehension in patients, and ties up regulatory bodies and the licensees in unnecessary and burdensome investigations. A more suitable definition of ME is required for permanent prostate brachytherapy.Methods and MaterialsThe American Society for Radiation Oncology (ASTRO) formed a working group of experienced clinicians to review the literature, assess the validity of current regulations, and make specific recommendations about the definition of an ME in permanent prostate brachytherapy.ResultsThe working group found that the current definition of ME in §35.3045 as “the total dose delivered differs from the prescribed dose by 20 percent or more” was not suitable for permanent prostate brachytherapy since the prostate volume (and hence the resultant calculated prostate dose) is dependent on the timing of the imaging, the imaging modality used, the observer variability in prostate contouring, the planning margins used, inadequacies of brachytherapy treatment planning systems to calculate tissue doses, and seed migration within and outside the prostate. If a dose-based definition for permanent implants is applied strictly, many properly executed implants would be improperly classified as an ME leading to a detrimental effect on brachytherapy. The working group found that a source strength-based criterion, of >20% of source strength prescribed in the post-procedure written directive being implanted outside the planning target volume is more appropriate for defining ME in permanent prostate brachytherapy.ConclusionsASTRO recommends that the definition of ME for permanent prostate brachytherapy should not be dose based but should be based upon the source strength (air-kerma strength) administered